1.
Myocardial salvaging effects and mechanisms of dipeptidyl peptidase-IV inhibitor Vildagliptin in experimental diabetes. Int Jour of Biomed Res [Internet]. 2016 May 30 [cited 2026 Apr. 21];7(5):276-82. Available from: https://ssjournals.co.in/index.php/ijbr/article/view/3273